Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology


Campi R., Brookman-May S. D., Subiela Henriquez J. D., AKDOĞAN B., Brausi M., Klatte T., ...More

EUROPEAN UROLOGY FOCUS, vol.5, no.6, pp.1029-1057, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 5 Issue: 6
  • Publication Date: 2019
  • Doi Number: 10.1016/j.euf.2018.04.001
  • Journal Name: EUROPEAN UROLOGY FOCUS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1029-1057
  • Hacettepe University Affiliated: Yes

Abstract

Context: To date, established risk factors for prostate cancer (PCa) are limited to age, race, family history, and certain genetic polymorphisms. Despite great research efforts, available evidence on potentially modifiable risk factors is conflicting. Moreover, most studies on PCa risk factors did not consider the impact of prostate-specific antigen (PSA) testing on PCa diagnosis.